跳到正文
WorldBrand.AI

奥姆尼凯尔

争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 5 条

  1. 2019

    美国司法部就处方药计费指控起诉 Omnicare 和 CVS

    提起诉讼

    纽约南区联邦检察官起诉 Omnicare 及其母公司 CVS Health，指称 Omnicare 因依据过期或其他无效处方配药而向联邦医疗项目欺诈性收费。CVS 否认指控并表示将为案件进行辩护。

    品牌回应

    • 否认 — CVS Health

      CVS refuted the charges in the lawsuit in a statement, saying, “We do not believe there is merit to these claims and we intend to vigorously defend the matter in court.

    • 否认 — CVS Health

      CVS Health spokesman Mike DeAngelis said the claims have no merit and the company plans to “vigorously defend the matter in court.”

    来源摘录

    • The lawsuit claims that Omnicare billed and dispensed drugs to elderly and disabled individuals based on “stale, invalid prescriptions,” including antipsychotics, anticonvulsants and antidepressants.
    • The DOJ has sued for damages and civil penalties, claiming the company submitted “hundreds of thousands of false claims to Medicare, Medicaid and TRICARE.
    • The Department of Justice said in federal court papers filed Tuesday that Omnicare’s pharmacies sent drugs to people living in residential facilities based on “stale, invalid prescriptions.” It accused the company of fraudulently billing government-funded programs like Medicaid and Medicare for drugs dispensed without a valid prescription from 2010 to 2018.
    来源

  2. 2013

    与Total Pharmacy Services收购相关的和解

    据报道，一项关于Omnicare 2004年收购Total Pharmacy Services相关涉嫌回扣的举报人诉讼已解决，Omnicare支付1720万美元，Total Pharmacy的所有者另行支付500万美元。

    来源

  3. 2012

    对PharMerica收购的反垄断挑战

    FTC提起诉讼，阻止Omnicare对PharMerica的敌意收购，声称合并将导致长期护理药房领域过度集中，并可能提高价格和政府支出。拟议收购被终止。

    来源

  4. 2010

    涉及疗养院运营商的《虚假申报法》案件

    根据《虚假申报法》提起的案件指控Omnicare向疗养院运营商付款以获取药房业务，可能涉及Medicare和Medicaid报销。Omnicare与联邦政府达成和解，支付1980万美元；相关疗养院方达成单独和解。

    来源

  5. 2009

    联邦回扣指控和9800万美元和解

    Omnicare支付9800万美元，以解决五起举报人诉讼和政府指控，指控其支付或索取回扣。指控包括涉及强生公司以及向疗养院患者推荐维思通的内容。Omnicare未承认不当行为。

    来源